Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1201–1250 of 18616
Andrew C. Warren, the Company’s Strategic Advisor to the Office of the CEO, will assume the additional duties of Executive Vice President, Interim Chief Financial Officer and principal financial officer of the Company after the departure of Mr. Chopra.
On June 3, 2025, Naveen Chopra, the Executive Vice President, Chief Financial Officer of Paramount Global (the “Company”), notified the Company of his decision to resign from his position, effective June 27, 2025.
Mr. Snyder is succeeding Mr. Thomas Amato, the current President and Chief Executive Officer of the Company.
appointed Mr. Thomas Snyder to the position of President and Chief Executive Officer of the Company (" CEO "), effective as of June 23, 2025
Daniel Cunha will become Chief Financial Officer of the Company, effective July 1, 2025.
On June 5, 2025, the Board of Directors appointed Jeanette M. Bjorkquist to serve as the Company’s principal financial officer in addition to her role as principal accounting officer.
Ms. Bjorkquist succeeds Jason A. Okazaki, who previously served as both the Company’s principal executive officer and principal financial officer.
Effective as of the Separation Date, the Board appointed Tammy Furlong, age 54, the Company’s Chief Financial Officer and Principal Financial and Accounting Officer, to succeed Mr. Ferra as President and Interim Chief Executive Officer
In connection with the Merger, the Company terminated the employment of Joseph J. Ferra, Jr., as the Company’s President, Chief Executive Officer, effective as of June 30, 2025
On June 8, 2025, Dr. Alan J. Tuchman resigned as Chief Executive Officer and director of the Company, effective June 8, 2025. Dr. Tuchman will serve as Chief Medical Officer of the Company.
Navid Mahmoodzadegan, Co-Founder and Co-President, will succeed Mr. Moelis as Chief Executive Officer and will also join the Board of Directors of the Company.
Scott Behrens will cease to serve as Executive Vice President, Chief Financial Officer and Chief Accounting Officer of the Company effective July 1, 2025.
On June 9, 2025, ACI Worldwide, Inc. (the “Company”) announced the appointment of Robert Leibrock as its Chief Financial Officer and Chief Accounting Officer effective July 1, 2025.
On June 9, 2025, Symbotic Inc. (the “Company”) announced the appointment of Izilda “Izzy” Martins as Chief Financial Officer and principal financial officer of the Company, effective August 9, 2025.
the following officers resigned from the offices indicated besides such officers’ names and ceased to serve in such offices: Kendall K. Young Chief Executive Officer and President Nicholas R. Balzo Chief Financial Officer and Treasurer Ann B. Harrington General Counsel and Secretary
the following officers resigned from the offices indicated besides such officers’ names and ceased to serve in such offices: Kendall K. Young Chief Executive Officer and President Nicholas R. Balzo Chief Financial Officer and Treasurer Ann B. Harrington General Counsel and Secretary
On June 9, 2025, FibroBiologics, Inc. (the “Company”) announced that Jason D. Davis has been appointed as the Company’s Chief Financial Officer, effective as of June 9, 2025 (the “Effective Date”).
On June 3, 2025, the Board of Directors of Hepion Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), approved the appointment of Dr. Kaouthar Lbiati, a director of the Company, as interim Chief Executive Officer, effective June 16, 2025.
Mr. Michael W. Sumruld will join the Company as Senior Vice President of Finance on September 1, 2025, and is expected to succeed Mr. Curtis as Chief Financial Officer upon Mr. Curtis’s retirement from such position.
On June 6, 2025, Tralisa Maraj, the Chief Financial Officer of LiveWire Group, Inc. (the “Company”), announced her resignation effective July 11, 2025 allowing sufficient time for a transition of her responsibilities before pursuing another opportunity outside the Company.
On June 3, 2025, Courtney Conigliaro notified the board of directors (the "Board") of Oaktree Acquisition Corp. III Life Sciences (the "Company") of her resignation as Chief Financial Officer of the Company.
On June 3, 2025, the Board appointed Thomas Sweeney as new Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.
Jay C. Horgen, previously President and Chief Executive Officer, will continue as Chief Executive Officer of the Company.
As previously disclosed, effective June 6, 2025, Natalie Russell, the Company’s Director of Accounting, will serve as the Company’s Interim Chief Financial Officer.
Effective June 6, 2025, Donald Alvarez stepped down as a member of the board of directors (the “Board”) and Chief Financial Officer of Cyngn Inc. (the “Company”).
on June 2, 2025, the Board of Directors of the Company appointed Michael Heraty, Vice President – Internal Audit & SOX Compliance to serve as Chief Accounting Officer of the Company following Sushmita Koyanagi’s promotion to Chief Financial Officer.
Sushmita Koyanagi, the Company's then-current Chief Accounting Officer, would take on the position of Chief Financial Officer.
Justin Pugh would step down from his role as the Company's interim Chief Financial Officer
On June 6, 2025, Julie Peffer, Chief Financial Officer, notified BigBear.ai Holdings, Inc. (“BigBear” or the “Company”) of her intention to pursue other opportunities outside of the Company.
On June 6, 2025, Sean R. Ricker was appointed acting Chief Financial Officer on an interim basis until the Company appoints a permanent replacement.
Mr. David M. Hession notified Dorman Products, Inc. (the “Company”) of his intention to retire as Senior Vice President and Chief Financial Officer (“CFO”) of the Company later this year.
On June 4, 2025, Jeffrey D. Harris, Treasurer and Chief Financial Officer of Glen Burnie Bancorp (the “ Company ”) since 2017, advised the Company’s Board of Directors that he intends to retire on June 30, 2025.
Upon and subject to the completion of the Merger, Joseph B. Reilly, Provident’s Director, President and Chief Executive Officer will join the respective Boards of Directors of the Company and Needham Bank.
On March 12, 2025, Omnicell, Inc. (“Omnicell” or the “Company”) filed a Current Report on Form 8-K disclosing that Nchacha Etta would step down from his role as Executive Vice President, Chief Financial Officer of the Company, effective September 15, 2025 or until a successor is named.
Thomas A. Houdek, the Chief Financial Officer and a Senior Vice President of the Company, notified the Company that he would be leaving the Company effective June 20, 2025.
Lyle D. Tick, the Company’s current President and Chief Concept Officer, had been promoted to the role of Chief Executive Officer and President effective June 5, 2025
Enrique Klix will assume the role of Chief Financial Officer of the Company
Oliver Matlock resigned as the Chief Financial Officer of the Company
On May 30, 2025, the Board of Directors of Apimeds Pharmaceuticals US, Inc. (the “Company”) appointed Erick J. Frim as Chief Financial Officer of the Company, replacing Mark Corrao.
On May 30, 2025, the Board of Directors of Apimeds Pharmaceuticals US, Inc. (the “Company”) appointed Erick J. Frim as Chief Financial Officer of the Company, replacing Mark Corrao.
On June 2, 2025, the Board determined to place Mr. Mewawalla on administrative leave from his position as Chief Executive Officer and President of the Company, effective immediately
appointed Mr. Kaliste Saloom to serve as Interim Chief Executive Officer of the Company, effective as of June 3, 2025.
Mr. P. Lancaster has resigned from his CEO with Mammoth effective as of June 30, 2025.
On June 1, 2025, MGT Capital Investments, Inc., (the “Company”) announced that it had appointed Mr. Jonathan Pfohl as its Chief Financial Officer.
On May 30, 2025, Catherine Leslie, the Chief Financial Officer of the Registrant, who has been doing both her CFO duties and leading that business, agreed to lead that business unit for the Registrant full time and advised the Registrant that she was resigning as the Registrant’s Chief Financial Officer, effective upon the date her successor, Ted Westwood, starts employment with the Registrant as described below.
On May 30, 2025, the Board of the Registrant appointed Theodore Westwood as the Chief Financial Officer of the Registrant, effective as of June 2, 2025, to serve until his successor is duly designated, or until his earlier death, resignation, retirement, disqualification, or removal from office.
On May 31, 2025, Eva Live Inc. (the “Company”) entered into an Employment Agreement with David Boulette to serve as its Chief Executive Officer.
On May 30, 2025, the Board of Directors (the “Board”) of TOMI Environmental Solutions, Inc. (the “Company”) appointed Mr. David Vanston as the Company’s Chief Financial Officer, effective immediately.
The appointment was made following the expiration of Mr. Nick Jennings’s offer letter to serve as the Interim Chief Financial Officer of the Company, as previously disclosed by the Company.
On May 30, 2025, Maurice van Tilburg notified Renovaro Inc. (the “Company”) of his intent to resign from the office of Chief Executive Officer of GEDi Cube B.V., a wholly-owned indirect subsidiary of the Company, which resignation was effective May 30, 2025.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.